Abivax S.A. (ABVX) is a pharmaceutical preparations company incorporated in France, listed on the Nasdaq. With a market capitalization of $8.9 billion, Abivax S.A. is a mid-cap company. The stock currently trades at $113.11, down 6.74% today, with a 52-week range of $4.77–$148.83.
No 10-K filings found.